$ABT ABBOTTS beats on earnings but we expect pullback
Abbotts quite simply does not miss earnings, a fantastic company and fantastic product in the ever increasing market of Diabetes treatment. Despite this we see a little stagnant price action lately and a pullback is quite possible.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.